Approval · Notice of Compliance 1074 · 2000
GEN-CEFACLOR: Notice of Compliance 1074
Issued February 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1074
- Date
- February 9, 2000
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- CECLOR (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-CEFACLOR | 02241637 | — |
| GEN-CEFACLOR | 02241641 | — |
| GEN-CEFACLOR | 02241642 | — |